These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11267438)

  • 1. A randomized comparison of an immunosuppressive strategy using tacrolimus and cyclosporine in black heart transplant recipients.
    Mehra MR; Uber PA; Park MH; Prasad AK; Scott RL
    Transplant Proc; 2001; 33(1-2):1606-7. PubMed ID: 11267438
    [No Abstract]   [Full Text] [Related]  

  • 2. Replacement of cyclosporine by tacrolimus for immunosuppression in heart transplant patients: safety and efficacy.
    Crespo-Leiro MG; Paniagua MJ; Mosquera I; Tabuyo T; De la Fuente L; Bouzas B; Rodriguez JA; Hermida LF; Juffé A; Castro-Beiras A
    Transplant Proc; 2002 Feb; 34(1):113-4. PubMed ID: 11959213
    [No Abstract]   [Full Text] [Related]  

  • 3. Incidence of humoral rejection in heart transplant recipients treated with tacrolimus or cyclosporine A.
    Behr TM; Richter K; Fischer P; Spes CH; Meiser B; Reichart B; Pongratz D; Feucht H; Theisen K; Angermann CE
    Transplant Proc; 1998 Aug; 30(5):1920-1. PubMed ID: 9723333
    [No Abstract]   [Full Text] [Related]  

  • 4. Ethnic disparity in clinical outcome after heart transplantation is abrogated using tacrolimus and mycophenolate mofetil-based immunosuppression.
    Mehra MR; Uber PA; Scott RL; Park MH
    Transplantation; 2002 Dec; 74(11):1568-73. PubMed ID: 12490790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial differences in clinical outcome using tacrolimus and mycophenolate mofetil immunosuppression in heart transplantation.
    Mehra MR; Uber PA; Scott RL; Prasad AK; Park MH
    Transplant Proc; 2001; 33(1-2):1613-4. PubMed ID: 11267442
    [No Abstract]   [Full Text] [Related]  

  • 6. New strategies using 'low-dose' mycophenolate mofetil to reduce acute rejection in patients following kidney transplantation.
    Ulsh PJ; Yang HC; Holman MJ; Ahsan N
    J Transpl Coord; 1999 Jun; 9(2):114-8. PubMed ID: 10703393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of tacrolimus as rescue therapy in children using a double immunosuppressive regimen after heart transplantation.
    Branco KC; Azeka E; Trindade E; Galas FR; Hajjar LA; Benvenuti L; Riso A; Tanamati C; Penha J; Auler JO; Jatene M
    Transplant Proc; 2012 Oct; 44(8):2483-5. PubMed ID: 23026625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
    Herzberg GZ; Rossi AF; Courtney M; Gelb BD
    J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superior prevention of acute rejection by tacrolimus vs. cyclosporine in heart transplant recipients--a large European trial.
    Grimm M; Rinaldi M; Yonan NA; Arpesella G; Arizón Del Prado JM; Pulpón LA; Villemot JP; Frigerio M; Rodriguez Lambert JL; Crespo-Leiro MG; Almenar L; Duveau D; Ordonez-Fernandez A; Gandjbakhch J; Maccherini M; Laufer G
    Am J Transplant; 2006 Jun; 6(6):1387-97. PubMed ID: 16686762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conversion of cyclosporine to tacrolimus for refractory or persistent myocardial rejection.
    Chan MC; Kwok BW; Shiba N; Cantin B; Valantine HA; Hunt SA
    Transplant Proc; 2002 Aug; 34(5):1850-2. PubMed ID: 12176601
    [No Abstract]   [Full Text] [Related]  

  • 11. Primary immunosuppression with tacrolimus and mycophenolate mofetil versus cyclosporine and azathioprine in heart transplant recipients.
    Teebken OE; Strüber M; Harringer W; Pichlmaier MA; Haverich A
    Transplant Proc; 2002 Jun; 34(4):1265-8. PubMed ID: 12072335
    [No Abstract]   [Full Text] [Related]  

  • 12. Adult heart transplantation under tacrolimus (FK506) immunosuppression: histopathologic observations and comparison to a cyclosporine-based regimen with lympholytic (ATG) induction.
    Tsamandas AC; Pham SM; Seaberg EC; Pappo O; Kormos RL; Kawai A; Griffith BP; Zeevi A; Duquesnoy R; Fung JJ; Starzl TE; Demetris AJ
    J Heart Lung Transplant; 1997 Jul; 16(7):723-34. PubMed ID: 9257254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical trial of FK506 in heart transplant patients in Taiwan: report of 7 cases with immunosuppression switch from cyclosporine to FK506.
    Ko WJ; Chou NK; Chen YS; Hsu RB; Wang SS; Chu SH
    Transplant Proc; 1998 Nov; 30(7):3339-41. PubMed ID: 9838474
    [No Abstract]   [Full Text] [Related]  

  • 14. Tacrolimus in heart transplant recipients: an overview.
    Patel JK; Kobashigawa JA
    BioDrugs; 2007; 21(3):139-43. PubMed ID: 17516709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Commentary on a comparison of tacrolimus and cyclosporine for immunosuppression after cadaveric renal transplantation.
    Cavaillé-Coll MW; Elashoff MR
    Transplantation; 1998 Jan; 65(1):142-5. PubMed ID: 9448161
    [No Abstract]   [Full Text] [Related]  

  • 16. Conversion at first rejection: a prospective trial comparing cyclosporine microemulsion with tacrolimus in renal transplant recipients.
    Dudley CR;
    Transplant Proc; 2001; 33(1-2):1034-5. PubMed ID: 11267179
    [No Abstract]   [Full Text] [Related]  

  • 17. De novo immunosuppression with sirolimus and tacrolimus in heart transplant recipients compared with cyclosporine and mycophenolate mofetil: a one-year follow-up analysis.
    Zucker MJ; Baran DA; Arroyo LH; Goldstein DJ; Neacy C; Mele L; Weinberg AD; Prendergast TW; Ribner HS
    Transplant Proc; 2005 Jun; 37(5):2231-9. PubMed ID: 15964386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose cellular IL-10 exacerbates rejection and reverses effects of cyclosporine and tacrolimus in Mouse cardiac transplantation.
    Li W; Lu L; Li Y; Fu F; Fung JJ; Thomson AW; Qian S
    Transplant Proc; 1997; 29(1-2):1081-2. PubMed ID: 9123209
    [No Abstract]   [Full Text] [Related]  

  • 19. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased rejection episodes in African-American renal transplant recipients receiving mycophenolate mofetil/tacrolimus therapy.
    Weber M; Deng S; Arenas J; Aradhye S; Grossman R; Shaw L; Naji A; Barker C; Brayman KL
    Transplant Proc; 1997 Dec; 29(8):3669-70. PubMed ID: 9414883
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.